Organoantimony
Medchemexpress LLC Gemigliptin tartrate | 1374639-74-3 | 99.5% | 639.45 | 5 MG
Gemigliptin tartrate is a highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. It exhibits potent anti-glycation properties and can be used for the research of advanced glycation end products (AGE)-related diabetic complications. This product is for research use only.
- Highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor
- IC50 of 10.3 nM for human recombinant DPP-4
- Exhibits potent anti-glycation properties
- Useful for research of advanced glycation end products (AGE)-related diabetic complications
- Dose-dependently inhibits the formation of AGE-BSA
- Suppresses the cross-linking of preformed AGE-BSA with rat tail tendon collagen
- Inhibits AGEs formation and AGE cross-links in vivo
- Dose-dependently inhibits plasma DPP-4 activity in various animal models
Medchemexpress LLC Gemigliptin (tartrate) | 1374639-74-3 | 99.5% | 639.45 | 1 ML
Gemigliptin tartrate, also known as LC15-0444 tartrate, is a highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC50 of 10.3 nM for human recombinant DPP-4. It demonstrates potent anti-glycation properties and can be used in research concerning advanced glycation end products (AGE)-related diabetic complications.
- Highly selective DPP-4 inhibitor.
- Exhibits potent anti-glycation properties.
- Useful for research on AGE-related diabetic complications.
- Dose-dependently inhibits AGE-BSA formation.
- Suppresses cross-linking of preformed AGE-BSA.
Medchemexpress LLC Gemigliptin tartrate hydrate | 1375415-82-9 | 99.8% | 666.49 | 5 MG
Gemigliptin tartrate hydrate is a selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor with an IC50 of 10.3 nM for human recombinant DPP-4. It exhibits potent anti-glycation properties and can be used for the research of advanced glycation end products (AGE)-related diabetic complications.
- Selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor
- Exhibits potent anti-glycation properties
- Useful for research of advanced glycation end products (AGE)-related diabetic complications
Medchemexpress LLC Gemigliptin tartrate hydrate | 1375415-82-9 | 99.8% | 666.49 | 100 MG
Gemigliptin (LC15-0444) tartrate hydrate is a selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. It exhibits potent anti-glycation properties and can be used for the research of advanced glycation end products (AGE)-related diabetic complications.
- Selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor
- Exhibits potent anti-glycation properties
- Used for the research of advanced glycation end products (AGE)-related diabetic complications
Medchemexpress LLC Gemigliptin tartrate hydrate | 1375415-82-9 | 99.8% | 666.49 | 50 MG
Gemigliptin tartrate hydrate is a selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor. It exhibits potent anti-glycation properties, making it suitable for research into advanced glycation end products (AGE)-related diabetic complications. This product is intended for research use only.
- Selective, reversible, and competitive DPP-4 inhibitor
- Potent anti-glycation properties
- Suitable for research of AGE-related diabetic complications
- Appears as a white to off-white solid
- For research use only
Medchemexpress LLC Gemigliptin tartrate hydrate | 1375415-82-9 | 99.8% | 666.49 | 25 MG
Gemigliptin tartrate hydrate is a selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor. It exhibits potent anti-glycation properties and can be used for the research of advanced glycation end products (AGE)-related diabetic complications.
- Selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor
- Exhibits potent anti-glycation properties
- Used for research of advanced glycation end products (AGE)-related diabetic complications
- IC50 of 10.3 nM for human recombinant DPP-4
Medchemexpress LLC Gemigliptin (tartrate) | 1374639-74-3 | 99.5% | 639.45 | 25 MG
Gemigliptin tartrate is a highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. It also shows potent anti-glycation properties and can be used for research on advanced glycation end products (AGE)-related diabetic complications.
- Highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor
- IC50 of 10.3 nM for human recombinant DPP-4
- Exhibits potent anti-glycation properties
- Can be used for the research of advanced glycation end products (AGE)-related diabetic complications